Attacking the "King of Women's Cancer" ovarian cancer, more than 20 domestic pharmaceutical companies deploy PARP inhibitors_Shenzhen Hotline

  • Post date May 8, 2022 — 13:25 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

002422 002793 300049 300376 East Group Co Hunan Fangsheng Pharmaceutical Jiangsu Hengrui Medicine Luoxin Pharmaceuticals Group Stock Sichuan Kelun Pharmaceutical Tasly Pharmaceutica Group Society Management Patent, Copyright, Trademark Research, Development Pharmaceutical Market, Exchange Diseases, Conditions Cancer Medicine Therapy Oncology

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data